Vaccine Hopes, Upbeat Data Lift Stocks
City Index | Jul 15, 2020 04:12AM ET
Vaccine optimism boosted risk appetite, lifting Asian markets overnight putting European bourses on track for a stronger start. Upbeat UK inflation data has added to the risk-on tone. Meanwhile, elevated US – Chinese tensions are broadly being shrugged off.
Risk sentiment has soared after Moderna (NASDAQ:MRNA) Inc said that its covid-19 vaccine candidate produced a “robust” immune response in all 45 patients in its early stage trial and without safety issues. The findings support further development of the vaccine and Phase 3 trials are expected to start at the end of this month.
A vaccine is the surest and quickest way for the global economy to bounce back to pre-coronavirus levels. Social distancing would no longer be needed, shops and particularly the leisure and hospitality sectors could return to business as usual. In shot a vaccine is the only way to recession-proof the economy against coronavirus. For this reason, the markets are so sensitive towards vaccine development news. As we move through the second half of the year, we can expect vaccine news to pick up, with Oxford University /AstraZeneca already in Phase 3 testing in south Africa and Brazil.
h3 UK Inflation surges/h3UK inflation surged +0.6% mom in June unexpectedly picking up from May and surpassing expectation s of 0.4%. On an annual basis, inflation increased by 1.4%, ahead of the 1.2% forecast. As lockdown measures were eased and the UK economy gradually reopened, demand has picked up boosting inflation. This is some well needed good news after yesterday’s GDP misery and has returned some faith that he UK economy is on the road to recovery, albeit a long road.
GBP/USD trades +0.3% targeting $1.26
h3 China troubles brushed off/h3As risk appetite rises stocks are pushing higher and the safe haven dollar has fallen out of favour. News that President Trump has ordered an end to Hong Kong’s special status in relation against China’s national security law in Hong Kong has broadly gone unnoticed. This follows reports that the UK will phase out the use of Huawei technology.
Coronavirus numbers are also being overshadowed by vaccine optimism. The tally in the US reached 3.4 million, with 136,000 deaths recorded. California has re-imposed lockdown measures across the hardest hit counties in the state amid record COVID numbers.
h3 EUR solid on stimulus hopes/h3On the currency markets, the euro is a star performer rising to 4 month highs on hopes that the economic recovery stimulus plan will be agreed after Germany’s Angela Merkel and Spain’s PM Pedro Sanchez committed to moving forward with the EU Fund.
FTSE Chart
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.